|
|
|
|
HAYWARD--- IMPAX Appoints Christopher Mengler, R.Ph., President of Global Pharmaceuticals Division
HAYWARD, Calif.--(BUSINESS WIRE)--IMPAX Laboratories, Inc.announced today the appointment of Christopher Mengler, R.Ph., as President of Global Pharmaceuticals, the Company's generic pharmaceutical division. In this role, Mr. Mengler...
|
|
|
Volcano Corporation Presentation at J.P. Morgan Conference to be Webcast
SAN DIEGO, Jan.6 /PRNewswire-FirstCall/ -- Volcano Corporation (NASDAQ:VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, said today that it...
|
|
|
Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in M
SAN DIEGO, Jan.5 /PRNewswire/ -- Research published in Nature Medicine shows that the disruption of the interactions between two small signaling proteins called chemokines by a highly potent drug-like peptide inhibits the development of...
|
|
|
BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization
NOVATO, Calif.and SAN DIEGO, Jan. 6 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and La Jolla Pharmaceutical Company (NASDAQ:LJPC) announced today that they have entered into an agreement to develop and...
|
|
|
International Stem Cell Corporation Discusses Recent Funding
OCEANSIDE, Calif.--(BUSINESS WIRE)--International Stem Cell Corporation (OTCBB:ISCO) announced on December 30 that it had received the first $1 million tranche of an anticipated private equity financing of up to $5 million to be funded over...
|
|
|
Aperio to Present at the JP Morgan 27th Annual Healthcare Conference
VISTA, Calif.--(BUSINESS WIRE)--Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, announced today that Dirk Soenksen, chief executive officer, will speak at the JP Morgan...
|
|
|
Aegis Therapeutics' Intravail Technology Selected as Winner in Pharmaceutical Technology's 'Innovations in Ph
SAN DIEGO--(BUSINESS WIRE)--Aegis Therapeutics LLC's Intravail transmucosal absorption enhancement technology has been selected as a winner in Pharmaceutical Technology's 'Innovations in Pharma Science Awards.' Intravail excipients make it...
|
|
|
Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist
Amira Pharmaceuticals, Inc.announced AM211, Amira's internally discovered oral drug candidate for the treatment and control of inflammatory and allergic diseases linked to the arachidonic acid pathway, is on target for submission of an...
|
|
|
Orexigen(R) Therapeutics to Speak at J.P. Morgan Healthcare Conference
Orexigen(R) Therapeutics, Inc.(NASDAQ:OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the 27th Annual J.P. Morgan Healthcare Conference. The details are as...
|
|
|
Halozyme Receives $5.5 Million Payment From Baxter
Halozyme Therapeutics, Inc.(NASDAQ:HALO), a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets, today announced...
|
